nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2017-3-9-17nefr-259Research ArticleПЕРЕДОВАЯ СТАТЬЯLEADING ARTICLEВРОЖДЕННЫЙ НЕФРОГЕННЫЙ НЕСАХАРНЫЙ ДИАБЕТ У ДЕТЕЙ И ПОДРОСТКОВ. НОВАЯ СТРАТЕГИЯ ТЕРАПИИCONGENITAL NEPHROGENIC DIABETES INSIPIDUS IN CHILDREN AND ADOLESCENTS. THE NEW STRATEGY OF THERAPYСавенковаН. Д.SavenkovaN. D.

проф., д.м.н., заведующая кафедрой факультетской педиатрии,

194100, Санкт-Петербург, ул. Литовская, д. 2

Prof., MD, PhD, DMedSci., Head of department of faculty pediatrics,

194100, St-Petersburg, Litovskaya st., 2

savenkova.n.spb@mail.ruСеменоваО. А.SemenovaO. A.

ассистент, к.м.н., кафедра факультетской педиатрии,

194100, Санкт-Петербург, ул. Литовская, д. 2

Assistant professor, MD, PhD, Department of faculty pediatrics,

194100, St-Petersburg, Litovskaya st., 2

semdoc@bk.ruСтепановаА. А.StepanovaA. A.

ассистент, к.м.н., кафедра факультетской педиатрии,

194100, Санкт-Петербург, ул. Литовская, д. 2

Assistant professor, MD, PhD, Department of faculty pediatrics,

194100, St-Petersburg, Litovskaya st., 2

ariwka@list.ruСанкт-Петербургский государственный педиатрический медицинский университетРоссияSaint-Petersburg State Pediatric Medical UniversityRussian Federation201725042017213917Copyright © Савенкова Н.Д., Семенова О.А., Степанова А.А., 20172017Савенкова Н.Д., Семенова О.А., Степанова А.А.Savenkova N.D., Semenova O.A., Stepanova A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/259

В обзоре приведены современные сведения о диагностике, течении, традиционной и новой стратегии терапии врожденного нефрогенного несахарного диабета (ВННД) у детей и подростков.

The article presents modern data on the diagnosis, course, traditional and new treatment strategy of congenital nephrogenic diabetes insipidus (NDI) in children and adolescents.

врожденный нефрогенный несахарный диабетдети и подросткитерапиясongenital nephrogenic diabetes insipiduschildren and adolescentstherapyReferencesOMIM: An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. Baltimore: Johns Hopkins Univ., 2015. Mode of access: http://www.moim.org/OMIM: An online catalog of human genes and genetic disorders [Electronic resource]. Electronic data. Baltimore: Johns Hopkins Univ., 2015. Mode of access: http://www.moim.org/Knoers N, Levtchenko EN. Nephrogenic diabetes insipidus. In: ED Avner, WE Harmon, P Niaudet, N Yoshikawa. Pediatric nephrology: 6-th edition. Berlin-Heidelberg: Springer-Verlag, Vol. 1, Sections 1-6, 2009; 1005-1018. ISBN 978-3-540-76341-32Knoers N, Levtchenko EN. Nephrogenic diabetes insipidus. In: ED Avner, WE Harmon, P Niaudet, N Yoshikawa. Pediatric nephrology: 6-th edition. Berlin-Heidelberg: Springer-Verlag, Vol. 1, Sections 1-6, 2009; 1005-1018. ISBN 978-3-540-76341-32McIraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 1892; ii:767-768McIraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet 1892; ii:767-768Williams RH, Henry C. Nephrogenic diabetes insipidus; transmitted by females and appearing during infancy in males. Annals of internal medicine 1947;27(1):84-95Williams RH, Henry C. Nephrogenic diabetes insipidus; transmitted by females and appearing during infancy in males. Annals of internal medicine 1947;27(1):84-95Наточин ЮВ. Клиническая физиология почек у детей. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 19-56 [Natochin JuV. Klinicheskaja fiziologija pochek u detej. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 19-56]Наточин ЮВ. Клиническая физиология почек у детей. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 19-56 [Natochin JuV. Klinicheskaja fiziologija pochek u detej. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 19-56]Bichet DG. Nephrogenic Diabetes Insipidus: Vasopressin Receptor Defect. In: Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, DW.Seldin. ELSEVIER 2009; 341-349Bichet DG. Nephrogenic Diabetes Insipidus: Vasopressin Receptor Defect. In: Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, DW.Seldin. ELSEVIER 2009; 341-349Wesche D, Deen P, Knoers N. Сongenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 2012;27(12):2183-2204. DOI 10.1007/s00467-012-2118-8Wesche D, Deen P, Knoers N. Сongenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 2012;27(12):2183-2204. DOI 10.1007/s00467-012-2118-8Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol 2009;29(3):178–195. doi: 10.1016/j.semnephrol.2009.03.008Sands JM, Layton HE. The physiology of urinary concentration: an update. Semin Nephrol 2009;29(3):178–195. doi: 10.1016/j.semnephrol.2009.03.008Sands JM, Layton HE. The urine concentrating mechanism and urea transporters. In: Alpern RJ, Hebert S.C., editors. The Kidney: Physiology and Pathophysiology. Vol. 1. San Diego: Academic Press; 2008; 1143–1178Sands JM, Layton HE. The urine concentrating mechanism and urea transporters. In: Alpern RJ, Hebert S.C., editors. The Kidney: Physiology and Pathophysiology. Vol. 1. San Diego: Academic Press; 2008; 1143–1178Deen PMT,Van Os CH, Knoers NVAM. Nephrogenic Diabetes Insipidus: Aquaporin-2 Defect. In:Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, W.Seldin. ELSEVIER 2009; 311-362Deen PMT,Van Os CH, Knoers NVAM. Nephrogenic Diabetes Insipidus: Aquaporin-2 Defect. In:Genetic Diseases of the Kidney. Edited by RP.Lifton, S.Somlo, G. Giebsch, W.Seldin. ELSEVIER 2009; 311-362Bockenhauer D. Diabetes Insipidus. In: Denis F.Geary, Franz Schaefer, editors. The Kidney: Comprehensive Pediatric Nephrology: MOSBY, 2008; 489–498Bockenhauer D. Diabetes Insipidus. In: Denis F.Geary, Franz Schaefer, editors. The Kidney: Comprehensive Pediatric Nephrology: MOSBY, 2008; 489–498Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 2016; 30 (2):263-276. doi: 10.1016/j.beem.2016.02.010Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant). Best Pract Res Clin Endocrinol Metab 2016; 30 (2):263-276. doi: 10.1016/j.beem.2016.02.010Klein JD, Wang Y, Blount MA et al. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol 2016;310(10):F1008Klein JD, Wang Y, Blount MA et al. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol 2016;310(10):F1008Klein JD, Fröhlich O, Blount MA et al. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol. 2006;17:2680–2686Klein JD, Fröhlich O, Blount MA et al. Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts. J Am Soc Nephrol. 2006;17:2680–2686Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11(10):576-588. doi: 10.1038/nrneph.2015.89Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11(10):576-588. doi: 10.1038/nrneph.2015.89Rascher W, Rosendahl W, Henrichs IA et al. Congenital nephrogenic diabetes insipidus – vasopressin and prostaglandins in respons to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol (1987) 1(3): 485-90Rascher W, Rosendahl W, Henrichs IA et al. Congenital nephrogenic diabetes insipidus – vasopressin and prostaglandins in respons to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol (1987) 1(3): 485-90Jakobsson В, Berg U. Effect of hydrochlorothiazide and indomethacine treatment оn renal function in nephrogenic diabetes insipidus. Acta Paediatr 1994; 83(5): 522-525Jakobsson В, Berg U. Effect of hydrochlorothiazide and indomethacine treatment оn renal function in nephrogenic diabetes insipidus. Acta Paediatr 1994; 83(5): 522-525Knoers N, Monnens LAH. Nephrogenic diabetes insipidus: clinical symptoms, pathogenlsis, genetics and treatment. Pediatr Neprol 1992; 6: 476-482Knoers N, Monnens LAH. Nephrogenic diabetes insipidus: clinical symptoms, pathogenlsis, genetics and treatment. Pediatr Neprol 1992; 6: 476-482Kilchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorthiazide and amiloride. Arch Dis Child 1999; 80: 548-552Kilchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorthiazide and amiloride. Arch Dis Child 1999; 80: 548-552Папаян КА, Савенкова НД. Особенности течения ренального несахарного диабета у детей при лечении гипотиазидом и амилоридом. В: Сборник трудов III нефрологического семинара. Санкт-Петербург (1995): 303-304 [Papayan KA, Savenkova ND Osobennosti techeniya renalnogo nesaharnogo diabeta u detey pri lechenii gipotiazidom i amiloridom. V: Sbornik trudov III nefrologicheskogo seminara. Sankt-Peterburg (1995): 303-304]Папаян КА, Савенкова НД. Особенности течения ренального несахарного диабета у детей при лечении гипотиазидом и амилоридом. В: Сборник трудов III нефрологического семинара. Санкт-Петербург (1995): 303-304 [Papayan KA, Savenkova ND Osobennosti techeniya renalnogo nesaharnogo diabeta u detey pri lechenii gipotiazidom i amiloridom. V: Sbornik trudov III nefrologicheskogo seminara. Sankt-Peterburg (1995): 303-304]Семенова ОА, Савенкова НД, Папаян КА. Врожденный нефрогенный несахарный диабет. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 241-249 [Semenova OA, Savenkova ND, Papajan KA. Vrozhdennyj nefrogennyj nesaharnyj diabet. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 241-249]Семенова ОА, Савенкова НД, Папаян КА. Врожденный нефрогенный несахарный диабет. В: Папаян АВ, Савенкова НД. Клиническая нефрология детского возраста. Руководство для врачей. С-Пб: «Левша. Санкт-Петербург»; 2008: 241-249 [Semenova OA, Savenkova ND, Papajan KA. Vrozhdennyj nefrogennyj nesaharnyj diabet. V: Papajan AV, Savenkova ND. Klinicheskaja nefrologija detskogo vozrasta. Rukovodstvo dlja vrachej. S-Pb: «Levsha. Sankt-Peterburg»; 2008: 241-249]Li JH, Chou CL, Li B et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest 2009; 119:3115. doi:10.1038/nrneph.2015.89Li JH, Chou CL, Li B et al. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest 2009; 119:3115. doi:10.1038/nrneph.2015.89Sands JM, Klein JD. Physiological insights into novel therapies for nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 2016;311(6):F1149-F1152. doi: 10.1152/ajprenal.00418.2016Sands JM, Klein JD. Physiological insights into novel therapies for nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 2016;311(6):F1149-F1152. doi: 10.1152/ajprenal.00418.2016Assadi F, Sharbaf FG. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus. Am J Nephrol 2015;42(1):65-69Assadi F, Sharbaf FG. Sildenafil for the Treatment of Congenital Nephrogenic Diabetes Insipidus. Am J Nephrol 2015;42(1):65-69Cheung PW, Nomura N, Nair AV et al. EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption. J Am Soc Nephrol 2016;27(10);3105-3116. DOI:10.1681/ASN.2015080903Cheung PW, Nomura N, Nair AV et al. EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption. J Am Soc Nephrol 2016;27(10);3105-3116. DOI:10.1681/ASN.2015080903Semenova OA, Savenkova ND. Long-term follow-up of patients from 13 families with congenital nephrogenic diabetes insipidus (NDI). Abstracts 42-nd Annual ESPN meeting, September 11-14 2008, Lyon, France. Pediatr Neprol 2008;23(9):1692Semenova OA, Savenkova ND. Long-term follow-up of patients from 13 families with congenital nephrogenic diabetes insipidus (NDI). Abstracts 42-nd Annual ESPN meeting, September 11-14 2008, Lyon, France. Pediatr Neprol 2008;23(9):1692

The authors declare that there are no conflicts of interest present.